Tandem Diabetes Care (TNDM) Change in Acquisitions & Divestments (2014 - 2026)

Tandem Diabetes Care's Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $27.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 58.58% year-over-year to $27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $219.0 million (down 23.94% YoY) and the FY2025 annual result came in at $257.1 million, down 16.12% from the prior year.
• Change in Acquisitions & Divestments was $27.0 million for Q1 2026 at Tandem Diabetes Care, down from $56.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $166.4 million in Q3 2022 and bottomed at $27.0 million in Q1 2026.
• A 5-year average of $100.4 million and a median of $96.4 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Peak annual rise in Change in Acquisitions & Divestments reached 215.56% in 2022, while the deepest fall reached 59.07% in 2022.
• Tandem Diabetes Care's Change in Acquisitions & Divestments stood at $146.6 million in 2022, then decreased by 10.81% to $130.7 million in 2023, then slumped by 48.42% to $67.4 million in 2024, then fell by 16.23% to $56.5 million in 2025, then sank by 52.29% to $27.0 million in 2026.
• Business Quant data shows TNDM's Change in Acquisitions & Divestments at $27.0 million in Q1 2026, $56.5 million in Q4 2025, and $54.1 million in Q3 2025.